Dimethylpolysiloxane vs Propylene Glycol: which is worse?

What is Dimethylpolysiloxane?

Dimethylpolysiloxane (PDMS, polydimethylsiloxane) is a silicone-based polymer used as an antifoaming agent in food and beverages. It prevents the formation of foam during food manufacturing and cooking. It is the same base material used in silicone cookware, medical devices, and contact lenses.

What is Propylene Glycol?

Propylene glycol is a synthetic organic compound used as a humectant, solvent, and emulsifier in food, pharmaceuticals, cosmetics, and industrial applications. It is produced from propylene oxide (derived from petroleum). Its chemical formula is C3H8O2.

Documented risks

Dimethylpolysiloxane: Dimethylpolysiloxane is generally considered non-toxic. It is not absorbed by the gut and passes through the digestive system unchanged. The FDA permits it at up to 10 ppm in cooking oils. EFSA's evaluation found no evidence of toxicity at permitted food use levels. There are no established cancer or reproductive toxicity concerns with PDMS at food use concentrations. The compound is the same base polymer used in many safe medical applications including contact lenses and breast implants (though the medical grade is different purity). The main environmental concern is PDMS persistence in the environment, as it is not readily biodegradable. Primary consumer concern is psychological rather than toxicological: the fact that it is used in both McDonald's frying oil and Silly Putty (which also contains PDMS) generates public attention, but the chemistries are actually different grades of the same polymer family.

Propylene Glycol: Propylene glycol is generally considered safe by the FDA and is metabolized by the liver to lactic acid and pyruvate (normal metabolites). However, at high doses — particularly from intravenous pharmaceutical formulations — propylene glycol can accumulate and cause lactic acidosis, kidney toxicity, and CNS effects. These effects are seen in critically ill patients receiving high-dose PG-containing intravenous medications, not from food consumption. In children and people with impaired liver or kidney function, PG accumulation may occur at lower doses than in healthy adults. Animal studies have found reproductive and developmental effects at high doses. EFSA's 2018 re-evaluation found no concerns at typical food use levels but noted the EU limits PG use as a direct food additive, using it only as a carrier solvent for permitted additives.